Non-alcoholic Fatty Liver Disease
📧 Sign up to get email alerts when something new happens for Non-alcoholic Fatty Liver Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-02-06Clinical Trial Update: Proliverenol Supplementation for Non-Alcoholic Fatty Liver Disease (NAFLD) [Phase 2]
A Phase 2 clinical trial evaluating Proliverenol supplementation for non-alcoholic fatty liver disease has completed.
-
CLINICAL_TRIALS research · 2025-02-06Clinical Trial Update: Assessment of the Prevalence of Steatotic Liver Disease Associated With Metabolic Dysfunction in Patients With Heterozygous Familial Hypercholesterolemia
A recruiting clinical trial assessing the prevalence of steatotic liver disease with metabolic dysfunction in patients with heterozygous fam…
-
CLINICAL_TRIALS trial_result · 2025-02-03Clinical Trial Update: Increased Risk of Non-alcoholic Fatty Liver Disease in Low Birth Weight Individuals
A clinical trial update indicates a study is examining the potential increased risk of non-alcoholic fatty liver disease in individuals with…
-
CLINICAL_TRIALS research · 2025-01-31Clinical Trial Update: LivQ-box® Parameters in the Diagnosis of Liver Inflammation
Clinical trial update describing the use of LivQ-box parameters to diagnose liver inflammation, with recruitment currently ongoing.
-
CLINICAL_TRIALS research · 2025-01-31Clinical Trial Update: Pyramidal Versus Continuous Training Effects on Fatty Liver [NA]
A Cairo University-sponsored clinical trial compares pyramidal versus continuous training to assess effects on non-alcoholic fatty liver dis…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-01-29Clinical Trial Update: Effects of Berberine in Reducing Abdominal Visceral Adipose Tissue Among Individuals with Obesity and NAFLD [Phase 4]
Phase 4 study evaluating berberine for reducing abdominal visceral adipose tissue in individuals with obesity and NAFLD has completed.
-
CLINICAL_TRIALS trial_result · 2025-01-27Clinical Trial Update: A Study of Multiple Doses of HM15211(Efocipegtrutide) in Obese Subjects With NAFLD [Phase 1]
Phase 1 study evaluating multiple-dose Efocipegtrutide (HM15211) in obese subjects with non-alcoholic fatty liver disease has completed, wit…
-
CLINICAL_TRIALS research · 2025-01-23Clinical Trial Update: Screening in Primary Care of Advanced Liver Fibrosis in NAFLD And/or Alcoholic Patients [NA]
A prospective study in primary care is recruiting to screen for advanced liver fibrosis among patients with non-alcoholic fatty liver diseas…
-
CLINICAL_TRIALS trial_result · 2025-01-14Clinical Trial Update: Vigabatrin and Insulin Sensitivity [Phase 2]
Phase 2 clinical trial evaluating vigabatrin for insulin sensitivity in non-alcoholic fatty liver disease and obesity has completed and resu…
-
CLINICAL_TRIALS research · 2025-01-13Clinical Trial Update: A Phase 1b Study of QX1206 in T2DM Patients With NAFLD [Phase 1]
Phase 1b trial update describing the ongoing study of QX1206 in patients with Type 2 Diabetes Mellitus and Non-alcoholic Fatty Liver Disease…
-
CLINICAL_TRIALS trial_result · 2025-01-10Clinical Trial Update: Effect of Obesity on Proton Pump Inhibitors [Phase 4]
Phase 4 trial completed evaluating whether obesity affects the use or effectiveness of proton pump inhibitors in obesity with NAFLD and GERD…
-
CLINICAL_TRIALS trial_result · 2024-12-27Clinical Trial Update: Improving Detection and Evidence-based Care of NAFLD in Latinx and Black Patients With Type 2 Diabetes [NA]
A completed clinical trial update from Duke University examining improved detection and evidence-based care of non-alcoholic fatty liver dis…
-
CLINICAL_TRIALS trial_result · 2024-12-18Clinical Trial Update: The Effect of Exercise Intervention on Insulin Resistance in Non-alcoholic Fatty Liver Disease (NAFLD) [NA]
Completed trial evaluating the effect of an exercise program on insulin resistance in non-alcoholic fatty liver disease.
-
CLINICAL_TRIALS research · 2024-12-16Clinical Trial Update: Feasibility Study of Deep Learning-based MDixon Quant for Quantitative Assessment of Chemotherapy-induced Fatty Liver [NA]
A feasibility study evaluating a deep learning-based MDixon Quant tool to quantify chemotherapy-induced fatty liver. The trial is sponsored …
-
CLINICAL_TRIALS research · 2024-12-16Clinical Trial Update: NAC- NAFLD and Cushing [NA]
A recruiting clinical trial at University Hospital Angers evaluating N-acetylcysteine for non-alcoholic fatty liver disease and Cushing synd…
-
CLINICAL_TRIALS trial_result · 2024-12-11Clinical Trial Update: Manual Therapy in Metabolic Liver Disease [NA]
A completed University of Seville clinical trial evaluated manual therapy for non-alcoholic fatty liver disease (NAFLD).
-
CLINICAL_TRIALS trial_result · 2024-12-09Clinical Trial Update: Lysosomal Acid Lipase Activity in Nonalcoholic Fatty Liver Disease
This update reports the completion of a clinical trial evaluating lysosomal acid lipase activity in individuals with non-alcoholic fatty liv…
-
CLINICAL_TRIALS trial_result · 2024-12-06Clinical Trial Update: Study of Eating Patterns With a Smartphone App and the Effects of Time Restricted Feeding in the Metabolic Syndrome [NA]
This clinical trial update notes that a study on smartphone app–assisted eating patterns and time-restricted feeding in metabolic syndrome h…
-
CLINICAL_TRIALS research · 2024-12-05Clinical Trial Update: Walking Program in Fatty Liver Children With Phenylketonuria [NA]
This clinical trial update indicates a walking program study for children with phenylketonuria and non-alcoholic fatty liver disease that is…
-
CLINICAL_TRIALS research · 2024-12-05Clinical Trial Update: The Effects of Tai Chi on Metabolic Dysfunction-associated Fatty Liver Disease in Middle-Aged and Older Adults [NA]
This ClinicalTrials.gov entry reports a study sponsored by Fujian Provincial Hospital to assess the effects of Tai Chi on metabolic dysfunct…
-
CLINICAL_TRIALS research · 2024-12-03Clinical Trial Update: Non-alcoholic Fatty Liver Disease in Low Birth Weight Individuals [NA]
A clinical trial update from the Steno Diabetes Center Copenhagen outlines a study on non-alcoholic fatty liver disease in individuals with …
-
CLINICAL_TRIALS research · 2024-11-27Clinical Trial Update: Establishment of Precise Histological Evaluation Criteria for NASH Fibrosis Reversal
This clinical trial aims to establish precise histological criteria to evaluate reversal of fibrosis in non-alcoholic steatohepatitis (NASH)…
-
CLINICAL_TRIALS trial_result · 2024-11-27Clinical Trial Update: A Feasibility Trial of OCM Supplements for the Treatment of NAFLD [EARLY_Phase 1]
A completed early-phase feasibility trial evaluating OCM dietary supplements for non-alcoholic fatty liver disease.
-
CLINICAL_TRIALS trial_result · 2024-11-22Clinical Trial Update: Tocotrienol as a Treatment for Non-alcoholic Fatty Liver Disease [NA]
Clinical trial evaluating tocotrienol for non-alcoholic fatty liver disease has completed.
-
CLINICAL_TRIALS trial_result · 2024-11-21Clinical Trial Update: Healthy Liver - Healthy Brain [NA]
A completed clinical trial conducted by the University of Texas at Austin studied the relationship between metabolic syndrome, non-alcoholic…